메레오 바이오파마 그룹 ADRMREO 주가

12 Health Care Stocks Moving In Tuesday's After-Market Session

♻️ 재탕European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading

European equities traded in the US as American depositary receipts were heading higher late Monday m

♻️ 재탕[SCHEDULE 13G/A] SCHEDULE 13G/A

♻️ 재탕[8-K] 중대 사건 — 8-K

[SCHEDULE 13G] SCHEDULE 13G

♻️ 재탕European Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading

European equities traded in the US as American depositary receipts were little changed late Wednesda

European Equities Traded in the US as American Depositary Receipts Decline Sharply in Tuesday Trading

European equities traded in the US as American depositary receipts were down significantly late Tues

Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates

LONDON, May 12, 2026 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced financial results for the first quarter ended March 31, 2026, and provided an update on recent corporate developments. “Based on extensive analysis of data across the two global Phase 3 studies of setrusumab in osteogenesis imperfecta in collaboration with our partner Ultragenyx, we believe there is basi

Mereo BioPharma Group Q1 EPS $(0.01), Inline

Mereo BioPharma Group (NASDAQ:MREO) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is a 50 percent increase over losses of $(0.02) per share from the same period last year.

[10-Q] 분기 실적 — 10-Q